Artificial intelligence (AI) to speed diagnosis, the impact of switching complement therapies, the safety of ravulizumab during pregnancy, and iptacopan outcomes are among the insights into paroxysmal ...
Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug resistance in mantle cell lymphoma through epigenetic profiling and the ...
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune therapies—paired with MRD monitoring and intensified maintenance strategies—is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results